Home Hyderabad DCA confiscates falsely advertised medicines

DCA confiscates falsely advertised medicines

0
DCA confiscates falsely advertised medicines

Telangana DCA Raids Store for Selling Medicines as Food Products

The Telangana State Drug Control Administration (DCA) conducted a raid at a store in Musheerabad and seized a large quantity of medicines that were falsely marketed as food products or nutraceuticals.

Officials discovered that Foron-XT Tablets, which contain Ferrous Ascorbate, Folic Acid, and Zinc Sulphate, were being sold under a food license. These tablets were manufactured by Maxtra Laboratories in Medchal-Malkajgiri District and marketed by Zyve Pharmaceuticals in Hyderabad.

DCA Director General V B Kamalasan Reddy stated that the product was wrongly produced under a food license issued by the Food Safety and Standards Authority of India (FSSAI). However, based on its composition, it is classified as a drug under the Drugs and Cosmetics Act, 1940.

Medicines like these must be manufactured under a proper drug license, following Good Manufacturing Practices (GMP) as required by law. They must also meet the quality standards set by the Indian Pharmacopoeia (IP).

In another raid, the DCA seized two Ayurvedic medicines—Podapathri Powder and Stone-Go Alkalizer Syrup—for making false claims about treating diabetes and kidney stones. These claims violate the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, which bans misleading advertisements about curing certain diseases.

Podapathri Powder was produced by Sri Amulya Herbals in Vijayawada, while Stone-Go Alkalizer Syrup was manufactured by Petal Healthcare and Ample Healthcare Pvt. Ltd. in Sangareddy District. Under the law, falsely advertising treatments for certain diseases can lead to penalties, including up to six months in prison, a fine, or both.

The raids were led by Drugs Inspectors P Renuka, J Ashwin Kumar, and T Praveen Kumar. Further investigations are ongoing, and legal action will be taken against those responsible.

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Exit mobile version